Study identifier:NIS-CFR-DUM-2007/9
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Survey on time to lipid-lowering drug implementation on dyslipidemic patients in general practice.
Dyslipidemia
-
No
-
All
3655
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Dec 2014 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|